SCM
CELG

Siphron Capital Management’s Celgene Corp CELG Stock Holding History

Siphron Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.17M Hold
12,332
– – 3.92% 5
2014
Q2 		$1.06M Sell
12,332
-12,880
-51% -$979K 3.59% 7
2014
Q1 		$1.76M Sell
25,212
-5,420
-18% -$429K 3.08% 19
2013
Q4 		$2.59M Sell
30,632
-22,668
-43% -$1.79M 3.75% 6
2013
Q3 		$4.11M Sell
53,300
-200
-0.4% -$14K 3.83% 5
2013
Q2 		$3.13M Buy
+53,500
New +$3.22M 3% 11

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Siphron Capital Management's CELG Position: Q3 2014 in Review

Siphron Capital Management held its Celgene Corp (CELG) position steady in Q3 2014 at 12,332 shares worth $1.17M. The position accounts for 3.92% of the portfolio, ranked #5.

Siphron Capital Management first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.11M in Q3 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Siphron Capital Management held 12,332 shares of Celgene Corp worth $1.17M as of Q3 2014.
  • Siphron Capital Management left its Celgene Corp share count unchanged in Q3 2014.
  • Celgene Corp made up 3.92% of Siphron Capital Management's portfolio in Q3 2014, its #5 holding.
  • Siphron Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • Siphron Capital Management's Celgene Corp position peaked at $4.11M in Q3 2013.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Siphron Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.